2393.HK

Yestar Healthcare Holdings Company Limited [2393.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

2393.HK Stock Summary

EPS has increased from the previous quarter and is now positive. (Quarter statements)

Earnings are expected to fall -100% next year

Profit margins (-0.24%) are lower than the previous year (-0.23%)

Top 10 Correlated Stocks

2393.HK

In the News

2393.HK Financial details

Company Rating

Neutral

Market Cap

118.91M

Income

-1.1B

Revenue

9.26B

Book val./share

-0.2

Cash/share

0.12

Dividend

Dividend %

Employees

713

Optionable

Shortable

Yes

Earnings

27 Mar 2024

P/E

-0.07

Forward P/E

PEG

P/S

0.02

P/B

-0.17

P/C

0.37

P/FCF

-0.65

Quick Ratio

0.08

Current Ratio

0.71

Debt / Equity

-4.1

LT Debt / Equity

-0.25

EPS (TTM)

-0.47

EPS next Y

EPS next Q

EPS this Y

-30814.29%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

-0.7%

Revenue Q/Q

1.51%

EPS Q/Q

-100.46%

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

-30%

ROE

-589%

ROC

5.13%

Gross Margin

17%

Oper. Margin

-16%

Profit Margin

-24%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.016-0.305

52W High

52W Low

RSI

Rel Volume

0.13

Avg Volume

11.21M

Volume

1.5M

Perf Week

-13.73%

Perf Month

-2.22%

Perf Quarter

-75.96%

Perf Half Y

-74.86%

Beta

0.129

Volatility

0%, 0.01%

Prev Close

4.76%

Price

0.044

Change

-4.35%

2393.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.04	2.05	1.74	2.1	1.84
Net income per share	0.12	0.08	-0.25	0	-0.43
Operating cash flow per share	0.09	0.18	0.28	0.3	-0.04
Free cash flow per share	0.07	0.16	0.25	0.28	-0.05
Cash per share	0.35	0.28	0.29	0.32	0.18
Book value per share	0.49	0.49	0.32	0.32	-0.18
Tangible book value per share	-0.66	-0.44	-0.22	-0.17	-0.31
Share holders equity per share	0.49	0.49	0.32	0.32	-0.18
Interest debt per share	0.86	0.8	0.83	0.76	0.94
Market cap	3.5B	3.18B	2.33B	2.2B	679.48M
Enterprise value	4.47B	4.54B	3.59B	3.41B	2.28B
P/E ratio	13.92	15.69	-3.94	661.99	-0.68
Price to sales ratio	0.79	0.65	0.57	0.45	0.16
POCF ratio	18.75	7.36	3.47	3.08	-7.41
PFCF ratio	23.27	8.16	3.93	3.31	-5.88
P/B Ratio	3.25	2.71	3.07	2.92	-1.66
PTB ratio	3.25	2.71	3.07	2.92	-1.66
EV to sales	1	0.92	0.88	0.69	0.53
Enterprise value over EBITDA	5.57	5.92	11.77	10.79	51.85
EV to operating cash flow	23.9	10.5	5.36	4.76	-24.88
EV to free cash flow	29.66	11.63	6.07	5.12	-19.75
Earnings yield	0.07	0.06	-0.25	0	-1.46
Free cash flow yield	0.04	0.12	0.25	0.3	-0.17
Debt to equity	1.62	1.51	2.43	2.2	-4.64
Debt to assets	0.3	0.29	0.4	0.36	0.56
Net debt to EBITDA	1.2	1.77	4.15	3.82	36.42
Current ratio	1.52	1.15	0.86	1.31	0.71
Interest coverage	5.26	4.59	1.27	1.44	-0.26
Income quality	0.74	2.13	-1.14	214.97	0.09
Dividend Yield	0.03	0.02	0.03	0	0
Payout ratio	0.38	0.28	-0.13	0	0
Sales general and administrative to revenue	0.07	0.07	0.08	0.07	0.08
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.43	0.39	0.3	0.27	0.11
Capex to operating cash flow	-0.19	-0.1	-0.12	-0.07	0.26
Capex to revenue	-0.01	-0.01	-0.02	-0.01	-0.01
Capex to depreciation	-0.24	-0.17	-0.32	-0.21	-0.1
Stock based compensation to revenue	0	0	0	0	0
Graham number	1.13	0.97	1.34	0.1	1.3
ROIC	0.16	0.13	0.06	0.01	-0.05
Return on tangible assets	0.08	0.06	-0.18	0	-0.33
Graham Net	-1.16	-1.04	-0.73	-0.68	-0.82
Working capital	1.07B	427.23M	-464.15M	662.79M	-1B
Tangible asset value	-1.45B	-1.06B	-521.15M	-408.14M	-721.08M
Net current asset value	-1.61B	-1.49B	-975.24M	-903.07M	-1.21B
Invested capital	1.62	1.51	2.43	2.2	-4.64
Average receivables	1.25B	1.47B	1.52B	1.53B	1.58B
Average payables	671.97M	650.43M	578.72M	607.78M	661.92M
Average inventory	825.92M	828.93M	686.47M	479.1M	387.38M
Days sales outstanding	113.05	116.17	130.81	117.77	133.39
Days payables outstanding	78.85	60.12	61.74	58.78	67.86
Days of inventory on hand	98.49	78.4	65.42	32.79	41.54
Receivables turnover	3.23	3.14	2.79	3.1	2.74
Payables turnover	4.63	6.07	5.91	6.21	5.38
Inventory turnover	3.71	4.66	5.58	11.13	8.79
ROE	0.23	0.17	-0.78	0	2.43
Capex per share	-0.02	-0.02	-0.03	-0.02	-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2021-06-30	2021-12-31	2022-06-30	2022-12-31	2023-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0.99	1.12	0.84	1	1.01
Net income per share	0.05	-0.05	-0.07	-0.35	0
Operating cash flow per share	0.09	0.21	-0.07	0.03	0.05
Free cash flow per share	0.08	0.2	-0.07	0.02	0.02
Cash per share	0.21	0.32	0.15	0.18	0.12
Book value per share	0.37	0.32	0.22	-0.18	-0.2
Tangible book value per share	-0.15	-0.18	-0.21	-0.31	-0.33
Share holders equity per share	0.37	0.32	0.22	-0.18	-0.2
Interest debt per share	0.76	0.71	0.79	0.81	0.81
Market cap	2.21B	2.19B	1.73B	679.48M	581.87M
Enterprise value	3.49B	3.39B	3.35B	2.28B	2.2B
P/E ratio	4.95	-5.04	-2.62	-0.21	40.22
Price to sales ratio	0.95	0.84	0.88	0.29	0.25
POCF ratio	10.04	4.42	-10.89	10.1	5.36
PFCF ratio	11.68	4.6	-10	11.8	12.31
P/B Ratio	2.56	2.9	3.4	-1.66	-1.26
PTB ratio	2.56	2.9	3.4	-1.66	-1.26
EV to sales	1.5	1.3	1.71	0.98	0.93
Enterprise value over EBITDA	17.08	30.5	57.27	-156.99	10.98
EV to operating cash flow	15.84	6.86	-21.1	33.94	20.26
EV to free cash flow	18.43	7.13	-19.37	39.63	46.53
Earnings yield	0.05	-0.05	-0.1	-1.22	0.01
Free cash flow yield	0.09	0.22	-0.1	0.08	0.08
Debt to equity	2.06	2.2	3.61	-4.64	-4.1
Debt to assets	0.38	0.36	0.44	0.56	0.55
Net debt to EBITDA	6.25	10.83	27.71	-110.26	8.07
Current ratio	0.89	1.31	1.3	0.71	0.7
Interest coverage	0	0	0	0	0
Income quality	1.97	-4.56	0.96	-0.08	30.01
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.07	0.06	0.08	0.08	0.08
Research and developement to revenue	0	0	0	0.01	0
Intangibles to total assets	0.28	0.27	0.26	0.11	0.1
Capex to operating cash flow	-0.14	-0.04	0.09	-0.14	-0.56
Capex to revenue	-0.01	-0.01	-0.01	0	-0.03
Capex to depreciation	-0.28	-0.15	-0.12	-0.09	-0.73
Stock based compensation to revenue	0	0	0	0	0
Graham number	0.63	0.58	0.59	1.18	0.08
ROIC	0.04	0.02	0	-0.05	0.02
Return on tangible assets	0.03	-0.03	-0.05	-0.28	0
Graham Net	-0.75	-0.69	-0.82	-0.82	-0.91
Working capital	-339.99M	662.79M	600.15M	-1B	-1.09B
Tangible asset value	-363.02M	-408.14M	-493.15M	-721.08M	-761.72M
Net current asset value	-846.06M	-903.07M	-1.01B	-1.21B	-1.27B
Invested capital	2.06	2.2	3.61	-4.64	-4.1
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	59.86	54.9	66.88	60.67	63.23
Days payables outstanding	35.61	26.81	36.95	31.35	33.48
Days of inventory on hand	27.87	14.96	25.26	19.19	20.78
Receivables turnover	1.5	1.64	1.35	1.48	1.42
Payables turnover	2.53	3.36	2.44	2.87	2.69
Inventory turnover	3.23	6.02	3.56	4.69	4.33
ROE	0.13	-0.14	-0.32	2.02	-0.01
Capex per share	-0.01	-0.01	-0.01	0	-0.03

2393.HK Frequently Asked Questions

What is Yestar Healthcare Holdings Company Limited stock symbol ?

Yestar Healthcare Holdings Company Limited is a CN stock and trading under the symbol 2393.HK

What is Yestar Healthcare Holdings Company Limited stock quote today ?

Yestar Healthcare Holdings Company Limited stock price is $0.044 today.

Is Yestar Healthcare Holdings Company Limited stock public?

Yes, Yestar Healthcare Holdings Company Limited is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 11.21M
Market Capitalization 118.91M
Employee 713
CEO Ms. Changxiang Liao
Headquarters Shanghai,CN
IPO Date 2013-10-11
Website https://www.yestarcorp.com

Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. The company also distributes in vitro diagnostic products. In addition, it engages in the biotechnology development activities; management of supply chain activities; and provision of freight transportation services. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.